Medline Industries, LP. v. C.R. Bard, Inc.

CourtDistrict Court, N.D. Illinois
DecidedJanuary 11, 2019
Docket1:14-cv-03618
StatusUnknown

This text of Medline Industries, LP. v. C.R. Bard, Inc. (Medline Industries, LP. v. C.R. Bard, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medline Industries, LP. v. C.R. Bard, Inc., (N.D. Ill. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

MEDLINE INDUSTRIES, INC., ) ) Plaintiff, ) ) v. ) 14 C 3618 ) C.R. BARD, INC., ) Judge John Z. Lee ) Defendant. )

MEMORANDUM OPINION AND ORDER Plaintiff Medline Industries, Inc. (“Medline”) brings this action against Defendant C.R. Bard, Inc. (“Bard”), alleging that Bard infringed three United States patents related to Medline’s Foley-catheter tray. The patents-in-suit are Nos. 8,446, 786 (“the ’786 patent”); 8,631,935 (“the ’935 patent”); and 8,678,190 (“the ’190 patent”). The parties seek construction of several terms that appear in the claims of these patents. For the reasons given herein, the Court construes the terms as stated in Appendix I. Background The three patents-in-suit relate to a tray for accommodating a catheter assembly and associated materials, including instruments and instructions. The ’786 patent was issued on May 28, 2013; the ’935 patent on January 21, 2014; and the ’190 Patent on March 5, 2014. 2d Am. Compl. ¶¶ 17–19, ECF No. 37. Medline alleges that Bard’s “Bardex I System” and “Bardex II System” infringe these patents. The parties identified several disputed claim terms in the patents-in-suit. The Court held claim construction hearings on two separate days pursuant to Markman v. Westview Instruments, Inc., 517 U.S. 370, 391 (1996).

Legal Standard Claim construction is a question of law to be decided by a judge. Markman, 517 U.S. at 391. Claim terms “are generally given their ordinary and customary meaning.” Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996). “[T]he ordinary and customary meaning . . . is the meaning that the term would have to a person of ordinary skill in the art in question at the time of the invention.” Phillips v. AWH Corp., 415 F.3d 1303, 1313 (Fed. Cir. 2005). A person having

ordinary skill in the art is assumed to read the claim term in the context of the entire patent. Id. “[T]he claims define the scope of the right to exclude; the claim construction inquiry, therefore, begins and ends in all cases with the actual words of the claim.” Teleflex, Inc. v. Ficosa N. Am. Corp., 299 F.3d 1313, 1324 (Fed. Cir. 2002); see Phillips, 415 F.3d at 1312. The context in which a term appears in a claim is instructive, and

“[b]ecause claim terms are normally used consistently throughout the patent, the usage of a term in one claim can often illuminate the meaning of the same term in other claims.” Phillips, 415 F.3d at 1314. “Differences among claims can also be a useful guide in understanding the meaning of particular claim terms.” Id. Moreover, “[t]he descriptive part of the specification aids in ascertaining the scope and meaning of the claims inasmuch as the words of the claims must be based on the description. The specification is, thus, the primary basis for construing the claims.” Id. at 1315 (quoting Standard Oil Co. v. Am. Cyanamid Co., 774 F.2d 448, 452 (Fed. Cir. 1985)). A particular embodiment described in the specification,

however, should not be read into a claim when the claim language is broader than the embodiment. SuperGuide Corp. v. DirecTV Enters., Inc., 358 F.3d 870, 875 (Fed. Cir. 2004). That said, a claim may be limited to its preferred embodiment if permitting expansive claim language would undermine the public notice requirements of 35 U.S.C. § 112. LizardTech, Inc. v. Earth Res. Mapping, Inc., 424 F.3d 1336, 1346 (Fed. Cir. 2005). In addition, “the prosecution history can often inform the meaning of the claim

language.” Phillips, 415 F.3d at 1317. For example, it may be used “as support for the construction already discerned from the claim language and confirmed by the written description” in the specification. 800 Adept, Inc. v. Murex Sec., Ltd., 539 F.3d 1354, 1365 (Fed. Cir. 2008). Moreover, the prosecution history may serve to “exclude any interpretation that was disclaimed during prosecution.” Chimie v. PPG Indus., Inc., 402 F.3d 1371, 1384 (Fed. Cir. 2005). However, a claim should not be narrowed

“simply by pointing to . . . disclos[ures] in the . . . prosecution history.” CCS Fitness, Inc. v. Brunswick Corp., 288 F.3d 1359, 1366 (Fed. Cir. 2002). Beyond the intrinsic evidence, in some cases, a “court will need to . . . consult extrinsic evidence . . . to understand, for example, the background science or the meaning of a term in the relevant art during the relevant time period.” Teva Pharm. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 841 (2015). “In cases where those subsidiary facts are in dispute, courts will need to make subsidiary factual findings about that extrinsic evidence.” Id. “[E]xperts may be examined to explain terms of art, and the state of the art, at any given time,” but they cannot be used to prove “the

proper or legal construction of any instrument of writing.” Id. Analysis The parties seek construction of the following claim terms: “catheter assembly”; “catheter package assembly”; “instruction manual”; “accessing an instruction manual”; “enclosing printed instructions”; and “a first compartment member having [at least one/an] inclined, stair-step[ped] contour.” I. “Catheter assembly”

The phrase “catheter assembly” appears in: claims 1, 17, 19, 21, 22, and 25 of the ’935 patent; claims 1, 6, 7, 9–11, 14, 15, and 17 of the ’190 patent; and claim 1 of the ’786 patent. Bard argues that a catheter assembly is “a medical device that includes a catheter connected via tubing to a drainage receptacle.” Def.’s Br. at 3, ECF No. 265. Medline agrees with this definition as a starting point but contends that a person having ordinary skill in the art would understand that the catheter

may only be a “Foley” catheter and that the non-catheter tubing component (“tubing component”) must be “coiled.” Pl.’s Br. at 7, ECF No. 278. The parties agree that “catheter assembly” has the same meaning in each of the patents. A. “Foley” Catheter Beginning with the claims, the word “Foley” does not appear in any of them. Nor does the word “Foley” appear in the written abstract, background, or “brief description of the drawings” sections of any of the specifications of the patents-in- suit. Moreover, each of the patents contain figures that—the parties agree—depict

catheter assemblies without Foley catheters. This can be seen in Figures 7, 8, and 10 of the ’935 patent.1 Similarly, Figures 7, 8, 10, and 22 in the ’190 patent present a catheter assembly with no Foley catheter.2 This also is true of Figures 7, 8, 10, 22, and 38 in the ’786 patent.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

800 Adept, Inc. v. Murex Securities, Ltd.
539 F.3d 1354 (Federal Circuit, 2008)
Helmsderfer v. Bobrick Washroom Equipment, Inc.
527 F.3d 1379 (Federal Circuit, 2008)
LizardTech, Inc. v. Earth Resource Mapping, Inc.
424 F.3d 1336 (Federal Circuit, 2005)
Rhodia Chimie & Rhodia, Inc. v. PPG Industries Inc.
402 F.3d 1371 (Federal Circuit, 2005)
Autogiro Company of America v. The United States
384 F.2d 391 (Court of Claims, 1967)
Aventis Pharma S.A. v. Hospira, Inc.
675 F.3d 1324 (Federal Circuit, 2012)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Teva Pharm. United States, Inc. v. Sandoz, Inc.
135 S. Ct. 831 (Supreme Court, 2015)
Superguide Corp. v. DirecTV Enterprises, Inc.
358 F.3d 870 (Federal Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Medline Industries, LP. v. C.R. Bard, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/medline-industries-lp-v-cr-bard-inc-ilnd-2019.